ORBIMED ADVISORS LLC Theseus Pharmaceuticals, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$98.84M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+4.88%
quarter

Theseus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 4.60M $5.8 17.04M
Q2 2022 share 0.00% 0 shares -102.25M $5.53 17.04M
Q1 2022 share Increase +1.21% 203K shares -17.02M $11.53 17.04M
Q4 2021 share Increase 0.00% 16.83M shares 213.51M $12.28 16.83M